Services
Launch capital and operating strategy
A six- to eight-week, executive-led engagement that answers one question for a company preparing for its first independent U.S. launch: how much capital will you need to launch, and what organization should you build?
Ideal client profile
Approval
18 to 30 months away, 24 ideal
Employees
About 10 to 75
Commercial build
Limited so far
Ahead
Financing, budget cycle, or board decision
Built for a company about two years from approval
The engagement is for a U.S. biotech that has already decided to commercialize independently and has a decision on launch investment coming up. Starting about 24 months before approval leaves time to sequence hires and vendor commitments, and to put the capital plan in front of the board before spending starts.
The questions it answers
- How much capital does commercialization preparation need?
- How should the company be structured for its first launch?
- Which leadership and operating roles should be hired, and when?
- What should be outsourced?
- What technology infrastructure is needed?
- Can AI and agentic workflows improve operating capacity or capital efficiency?
- What happens if approval or launch is delayed?
- How should the commercialization investment plan be presented to the board and investors?
Five phases over eight weeks
Wk 1
Wk 2
Wk 3
Wk 4
Wk 5
Wk 6
Wk 7
Wk 8
Wk 1
Diagnose
Leadership interviews, current organization, budgets, launch milestones
Baseline assessment and assumptions
Management approves assumptions
Wk 2
Set readiness requirements
Capability inventory, dependencies, readiness gates
Commercial-readiness requirements
Management approves assumptions
Wk 3–4
Design operating alternatives
Organization, FTEs, hiring, vendors, AI and technology
Three operating-model alternatives
Management approves assumptions
Wk 5–6
Model the investment
Compensation, quarterly cash, vendors, technology, sensitivity scenarios
Editable financial model
Management approves assumptions
Wk 7–8
Recommend and roadmap
Evaluate alternatives, facilitate executive decisions, implementation plan
Board-ready recommendations and roadmap
Management approves assumptions at a checkpoint between each phase.
Six weeks is possible when inputs are readily available.
What management receives
Pre-launch capital model
An editable workbook with role-level compensation, hiring dates, outsourced services, technology, AI investment, quarterly expense, and scenario sensitivities.
Commercial organizational design
The target organization, with each activity assigned to an employee, a vendor, software, an agent, or a shared service.
Operating-model alternatives
Traditional, AI-Enhanced, and AI-First designs built on the same assumptions.
Technology and vendor roadmap
The quarterly sequence of systems, vendor commitments, and AI capabilities through launch.
Launch-readiness assessment
A commercial-readiness matrix and milestone roadmap covering capabilities, dependencies, systems, vendors, and procedures.
Executive recommendations
A recommended operating model, decision gates, and a presentation for the board.
What management provides
A short list of inputs, most of which already exist in board materials and budgets.
- Product and approval timing
- Commercial strategy
- Current organization chart
- Cash runway and budgets
- Vendors and existing commitments
- Current technology
- Milestones
- Existing plans and board materials
Data boundary
Aggregate business data only. RF Consulting does not need or accept identifiable patient information.
Scope
The engagement covers commercial readiness and organizational investment. It can incorporate management’s clinical, regulatory, and manufacturing budgets into a consolidated capital view but does not build or validate them.
Separate engagements
- Executive recruiting
- Vendor contracting
- CRM or ERP implementation
- Production AI engineering
- Full revenue or gross-to-net forecasting
Preparing for a financing, a budget cycle, or a board decision on launch investment?
Send a short note on where the program stands. Rommel replies personally.